Semaglutide mimics the effects of a natural hormone in your body called GLP-1 (glucagon-like peptide-1). It works by slowing down digestion, reducing appetite, and increasing feelings of fullness, helping you to eat less and lose weight
Tirzepatide is unique in its ability to mimic two naturally occurring hormones in the body: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism helps reduce appetite, and promote significant weight loss. By enhancing the body's natural processes, Tirzepatide supports better metabolic health and weight management.
Semaglutide mimics the natural hormone GLP-1, which helps reduce appetite, slow digestion, and increase feelings of fullness, making it easier to eat less and lose weight.
Semaglutide leads to significant weight loss by reducing appetite and promoting fullness. It’s a once-weekly injection that helps with weight management and is clinically proven to help people lose weight.
Semaglutide targets GLP-1, while Tirzepatide works on both GLP-1 and GIP hormones. Tirzepatide provides a more comprehensive approach to weight loss and blood sugar control, leading to greater weight reduction in some studies.
Tirzepatide helps with significant weight loss by mimicking two hormones, GLP-1 and GIP, which reduce appetite, improve metabolic health, and support better blood sugar control.
Both Semaglutide and Tirzepatide aid in weight loss by reducing appetite. Semaglutide targets only GLP-1, while Tirzepatide offers a dual hormone approach (GLP-1 + GIP) for more comprehensive weight management and blood sugar control.
Sunday: Closed